| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.80▼ | 1.80▼ | 1.80▼ | 1.77▲ | 1.58▲ |
| MA10 | 1.80▼ | 1.80▼ | 1.77▲ | 1.72▲ | 1.65▲ |
| MA20 | 1.78▲ | 1.76▲ | 1.75▲ | 1.55▲ | 2.66▼ |
| MA50 | 1.74▲ | 1.71▲ | 1.67▲ | 1.67▲ | 5.77▼ |
| MA100 | 1.66▲ | 1.55▲ | 1.57▲ | 2.89▼ | 6.67▼ |
| MA200 | 1.63▲ | 1.69▲ | 1.70▲ | 5.93▼ | 11.77▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.000▲ | 0.000▲ | 0.054▲ | 0.096▲ |
| RSI | 55.587▲ | 56.864▲ | 59.644▲ | 56.575▲ | 39.036▼ |
| STOCH | 35.833 | 67.083 | 80.000 | 85.258▲ | 37.099 |
| WILL %R | -80.000▼ | -26.667 | -26.667 | -16.840▲ | -74.704 |
| CCI | -49.123 | 33.451 | 49.396 | 97.841 | -15.699 |
|
Saturday, January 17, 2026 09:04 AM
Detailed price information for Artelo Biosciences Inc (ARTL-Q) from The Globe and Mail including charting and trades.
|
|
Wednesday, December 03, 2025 12:30 AM
SOLANA BEACH, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating ...
|
|
Wednesday, November 12, 2025 04:59 AM
SOLANA BEACH, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (ARTL) (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/01/26 | 1.80 | 1.80 | 1.79 | 1.79 | 11,721 |
| 27/01/26 | 1.74 | 1.8791 | 1.74 | 1.82 | 42,552 |
| 26/01/26 | 1.69 | 1.79 | 1.67 | 1.79 | 13,842 |
| 23/01/26 | 1.73 | 1.7699 | 1.70 | 1.73 | 28,399 |
| 22/01/26 | 1.65 | 1.77 | 1.65 | 1.73 | 47,726 |
| 21/01/26 | 1.69 | 1.77 | 1.6301 | 1.71 | 56,246 |
| 20/01/26 | 1.66 | 1.76 | 1.63 | 1.66 | 28,488 |
| 16/01/26 | 1.62 | 1.77 | 1.59 | 1.71 | 107,448 |
| 15/01/26 | 1.61 | 1.75 | 1.57 | 1.66 | 59,079 |
| 14/01/26 | 1.58 | 1.72 | 1.535 | 1.61 | 205,547 |
|
|
||||
|
|
||||
|
|